Special Issue

Natural products for neurological disorders

Submission Deadline: 1 Dec 2021

Guest Editors

  • Portrait of Guest Editor Ghulam  Md Ashraf
  • Portrait of Guest Editor Sahab  Uddin

    Sahab Uddin MD

    Department of Pharmacy, Southeast University, Dhaka, Bangladesh,Pharmakon Neuroscience Research Network, Dhaka, Bangladesh

    Interests: Alzheimer’s disease; Pharmacology; Physiology; Neuroscience

Special Issue Information

Dear Colleagues,

Neurological disorders are prevalent and present a serious public health concern. There has been no progress in designing successful treatments, despite substantial breakthroughs in our knowledge of neurological diseases. There are more than 600 neurological disorders including intellectual disabilities, neuromuscular disorders, autism, attention deficit disorder, brain cancer, and cerebral palsy, etc. Some neurological disorders occur before birth and are congenital. Tumors, degeneration, injuries, diseases or systemic abnormalities may be the cause of many neurological conditions. All neurological disorders arise from disruption to the nervous system, regardless of the cause. In recent decades, substantial attempts have been made to identify drugs that can mitigate these neurological diseases. Natural products are small molecules found in various natural sources. In the treatment of all human diseases, including neurological disorders, natural products have an emerging role. They are considered to be the single most significant source of drug leads. The importance of natural products derived from plants for the treatment of neurological disorders is clear from the fact that most of the earlier medications used to treat brain disorders were derived from plants. 
In this special thematic issue, we welcome experts to contribute their articles related to the application of natural products in different neurological disorders.

Dr. Ghulam Md Ashraf and Mr. Md. Sahab Uddin

Guest Editors

Keywords

  • Neurological disorders
  • Neurodegeneration
  • Alzheimer's Disease
  • Brain
  • Central Nervous System
  • Dementia
  • Drug Delivery
  • Drug Targeting
  • Huntington’s diseases
  • Amyotrophic lateral sclerosis
  • Mild Cognitive Impairment
  • Neurodegenerative Disorders
  • Neuroproteomics
  • Parkinson’s disease
  • Proteomics
  • Therapeutic Agents
  • Natural Compounds
  • Natural Products
  • Drugs

Published Paper (1)